292 related articles for article (PubMed ID: 18191838)
1. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
Cunha GM; Canas PM; Melo CS; Hockemeyer J; Müller CE; Oliveira CR; Cunha RA
Exp Neurol; 2008 Apr; 210(2):776-81. PubMed ID: 18191838
[TBL] [Abstract][Full Text] [Related]
2. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
[TBL] [Abstract][Full Text] [Related]
3. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
Tajima H; Kawasumi M; Chiba T; Yamada M; Yamashita K; Nawa M; Kita Y; Kouyama K; Aiso S; Matsuoka M; Niikura T; Nishimoto I
J Neurosci Res; 2005 Mar; 79(5):714-23. PubMed ID: 15678515
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
[TBL] [Abstract][Full Text] [Related]
7. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
Melani A; Cipriani S; Vannucchi MG; Nosi D; Donati C; Bruni P; Giovannini MG; Pedata F
Brain; 2009 Jun; 132(Pt 6):1480-95. PubMed ID: 19359287
[TBL] [Abstract][Full Text] [Related]
8. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.
Cunha RA; Agostinho PM
J Alzheimers Dis; 2010; 20 Suppl 1():S95-116. PubMed ID: 20182043
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Domenici MR; Scattoni ML; Martire A; Lastoria G; Potenza RL; Borioni A; Venerosi A; Calamandrei G; Popoli P
Neurobiol Dis; 2007 Nov; 28(2):197-205. PubMed ID: 17720507
[TBL] [Abstract][Full Text] [Related]
10. NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat.
Guan J; Zhang R; Dale-Gandar L; Hodgkinson S; Vickers MH
Behav Brain Res; 2010 Jul; 210(2):221-8. PubMed ID: 20188767
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Canas PM; Porciúncula LO; Cunha GM; Silva CG; Machado NJ; Oliveira JM; Oliveira CR; Cunha RA
J Neurosci; 2009 Nov; 29(47):14741-51. PubMed ID: 19940169
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
[TBL] [Abstract][Full Text] [Related]
14. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
Brambilla R; Cottini L; Fumagalli M; Ceruti S; Abbracchio MP
Glia; 2003 Aug; 43(2):190-4. PubMed ID: 12838511
[TBL] [Abstract][Full Text] [Related]
15. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid.
Hruska Z; Dohanich GP
Horm Behav; 2007 Sep; 52(3):297-306. PubMed ID: 17583706
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
Pagnussat N; Almeida AS; Marques DM; Nunes F; Chenet GC; Botton PH; Mioranzza S; Loss CM; Cunha RA; Porciúncula LO
Br J Pharmacol; 2015 Aug; 172(15):3831-45. PubMed ID: 25939452
[TBL] [Abstract][Full Text] [Related]
19. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues.
Kunesová G; Hlavácek J; Patocka J; Evangelou A; Zikos C; Benaki D; Paravatou-Petsotas M; Pelecanou M; Livaniou E; Slaninova J
Peptides; 2008 Nov; 29(11):1982-7. PubMed ID: 18647630
[TBL] [Abstract][Full Text] [Related]
20. The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
Pitsikas N; Zisopoulou S; Pappas I; Sakellaridis N
Behav Brain Res; 2008 Apr; 188(2):304-9. PubMed ID: 18164078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]